Sustainability | March 06, 2025
J. B. Chemicals & Pharmaceuticals announces DJSI score of 77
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
The company recorded revenue of Rs 528crore as compared to Rs 444 crore, registering a growth of 19% over the corresponding quarter ended 31st March 2020
Subscribe To Our Newsletter & Stay Updated
